---
figid: PMC5840543__EMMM-10-e8313-g009
figtitle: Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small
  cell lung cancer
organisms:
- Homo sapiens
- Mus musculus
- vectors
- Moloney murine leukemia virus
pmcid: PMC5840543
filename: EMMM-10-e8313-g009.jpg
figlink: /pmc/articles/PMC5840543/figure/emmm201708313-fig-0008/
number: F8
caption: In TKI‐resistant EGFR mutant cells, the Gefitinib‐untargetable palmitoylated
  EGFR positively impinges on FASN, therefore promoting tumor cell growth via the
  Akt pathway. Palmitoylation is a process where a 16‐carbon fatty acid palmitate,
  synthesized by FASN, is covalently attached to proteins. Pharmacological inhibition
  of FASN by Orlistat inhibits EGFR palmitoylation and restricts tumor cell survival.
papertitle: Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small
  cell lung cancer.
reftext: Azhar Ali, et al. EMBO Mol Med. 2018 Mar;10(3):e8313.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9609563
figid_alias: PMC5840543__F8
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC5840543__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5840543__EMMM-10-e8313-g009.html
  '@type': Dataset
  description: In TKI‐resistant EGFR mutant cells, the Gefitinib‐untargetable palmitoylated
    EGFR positively impinges on FASN, therefore promoting tumor cell growth via the
    Akt pathway. Palmitoylation is a process where a 16‐carbon fatty acid palmitate,
    synthesized by FASN, is covalently attached to proteins. Pharmacological inhibition
    of FASN by Orlistat inhibits EGFR palmitoylation and restricts tumor cell survival.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - Srebf1
  - Fasn
  - Akt1
  - EGFR
  - SREBF1
  - FASN
  - AKT1
  - AKT2
  - AKT3
  - Gefitinib
  - Palmitate
  - Orlistat
---
